News | Heart Valve Technology | December 07, 2017

Edwards Acquires Harpoon Medical

Acquisition brings beating-heart repair technology for degenerative mitral regurgitation into Edwards portfolio

Edwards Acquires Harpoon Medical

December 7, 2017 — Edwards Lifesciences Corp. announced the acquisition of Harpoon Medical Inc., a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR). Edwards announced a structured upfront investment in Harpoon in 2015, with an exclusive option to acquire the company.

Under the terms of the merger agreement, Edwards paid $100 million in cash for Harpoon at closing on Dec. 1. In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.

The Harpoon system is designed to facilitate echocardiography-guided repair of mitral valve regurgitation, by stabilizing the prolapsed mitral valve leaflet to restore proper coaptation and valve function. The Harpoon device is currently investigational and not available for commercial use. It is expected to receive CE Mark approval soon.

"There are a significant number of patients currently undergoing mitral valve surgery that we believe can benefit from Harpoon's therapy during a minimally invasive, beating-heart procedure," said device inventor James S. Gammie, M.D., chairman of the company's scientific advisory board and professor and chief of cardiac surgery at the University of Maryland School of Medicine. "This therapy offers the potential for earlier treatment of degenerative mitral valve disease with faster recovery and less morbidity, while also providing the opportunity for more consistent procedures and outcomes for patients."

Read the article "Harpoon Mitral Valve Repair System Found Safe and Effective."

Read the article "Advances and Future Directions for Transcatheter Valves."

For more information: www.edwards.com, www.harpoonmedical.com


Related Content

News | Cardiovascular Business

June 11, 2024 — Columbia University Irving Medical Center’s CUIMC Division of Cardiology has launched the Mitral and ...

Home June 11, 2024
Home
Feature | Cardiovascular Business

June 7, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the ...

Home June 07, 2024
Home
News | Cardiovascular Business

June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care ...

Home June 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a look at the Top 10 pieces of content viewers were reading during the month of May. 1. American College of ...

Home June 04, 2024
Home
News | Cardiovascular Business

May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...

Home May 31, 2024
Home
News | Cardiovascular Business

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

Home May 22, 2024
Home
News | Cardiovascular Business

May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Home May 14, 2024
Home
News | Cardiovascular Business

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

Home May 03, 2024
Home
News | Cardiovascular Business

April 29, 2024 — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure ...

Home April 29, 2024
Home
Subscribe Now